Biblio Discovery — Demo Discovery Service

20 results for "Maple, Hannah"

Showing 1–20 · 0.94 seconds · RSS

  1. Journal Article Full text

    Horseshoe polycystic kidney

    Maple, Hannah; Drage, Martin

    Clin Kidney J · 2013 · English · PubMed Central

  2. Journal Article Full text

    Developing degraders: principles and perspectives on design and chemical space

    Maple, Hannah J.; Clayden, Nat; Baron, Anne et al.

    Medchemcomm · 2019 · English · PubMed Central

    Degraders (e.g. PROTACs, SNIPERs, degronimers etc.) are a new modality offering increasing potential both as tools for basic research and therapeutic development. They occupy chemical space that lies outside the classical Lipinski ‘Rule of 5’, which poses fresh challenges for achieving cell…

  3. Journal Article Full text

    Challenges and Opportunities in the Supply of Living Kidney Donation in the UK National Health Service: An Economic Perspective

    Morris, Tiyi; Maple, Hannah; Norton, Sam et al.

    Transplantation · 2022 · English · PubMed Central

    End-stage kidney disease is a significant burden on the healthcare systems of many countries, and this is likely to continue because of an increasingly aging and comorbid population. Multiple studies have demonstrated a significant clinical benefit in transplantation when compared with dialysis…

  4. Journal Article Full text

    Donating a Kidney to a Stranger: Are Healthcare Professionals Facilitating the Journey? Results From the BOUnD Study

    Maple, Hannah; Gogalniceanu, Petrut; Gare, Rebecca et al.

    Transpl Int · 2023 · English · PubMed Central

    Unspecified kidney donors (UKDs) are approached cautiously by some transplant professionals. The aim of this study was to interrogate the views of UK transplant professionals towards UKDs and identify potential barriers. A purposely designed questionnaire was validated, piloted and distributed…

  5. Journal Article Full text

    Clinical Outcomes and Quality of Life of Patients Receiving Multi-Solid-Organ Transplants in Childhood Are Excellent: Results From a 20-Year Cohort Study

    Paessler, Alicia; Maple, Hannah; Cortes, Miriam et al.

    Transpl Int · 2024 · English · PubMed Central

    Advances in medicine allow children with previously fatal conditions to survive longer and present as transplant candidates; some requiring multiple solid-organ transplants (MSOT). There is limited data on clinical outcomes and no data on quality of life (QoL). In this mixed methods cohort study…

  6. Journal Article Full text

    α4/α9 Integrins Coordinate Epithelial Cell Migration Through Local Suppression of MAP Kinase Signaling Pathways

    Hight-Warburton, Willow; Felix, Robert; Burton, Andrew et al.

    Front Cell Dev Biol · 2021 · English · PubMed Central

    Adhesion of basal keratinocytes to the underlying extracellular matrix (ECM) plays a key role in the control of skin homeostasis and response to injury. Integrin receptors indirectly link the ECM to the cell cytoskeleton through large protein complexes called focal adhesions (FA). FA also function…

  7. Journal Article Full text

    The Effect of Pre-Analytical Conditions on Blood Metabolomics in Epidemiological Studies

    Santos Ferreira, Diana L.; Maple, Hannah J.; Goodwin, Matt et al.

    Metabolites · 2019 · English · PubMed Central

    Serum and plasma are commonly used in metabolomic-epidemiology studies. Their metabolome is susceptible to differences in pre-analytical conditions and the impact of this is unclear. Participant-matched EDTA-plasma and serum samples were collected from 37 non-fasting volunteers and profiled using a…

  8. Journal Article Full text

    Exploring Staff Attitudes Towards Unspecified Kidney Donors in the United Kingdom: Results From the BOUnD Study

    Zuchowski, Mira; Mamode, Nizam; Draper, Heather et al.

    Transpl Int · 2023 · English · PubMed Central

    Unspecified kidney donation (UKD) has made substantial contributions to the UK living donor programme. Nevertheless, some transplant professionals are uncomfortable with these individuals undergoing surgery. This study aimed to qualitatively explore the attitudes of UK healthcare professionals…

  9. Journal Article Full text

    Donor Autonomy and Self-Sacrifice in Living Organ Donation: An Ethical Legal and Psychological Aspects of Transplantation (ELPAT) View

    Mamode, Nizam; Van Assche, Kristof; Burnapp, Lisa et al.

    Transpl Int · 2022 · English · PubMed Central

    Clinical teams understandably wish to minimise risks to living kidney donors undergoing surgery, but are often faced with uncertainty about the extent of risk, or donors who wish to proceed despite those risks. Here we explore how these difficult decisions may be approached and consider the…

  10. Journal Article Full text

    Understanding barriers and outcomes of unspecified (non-directed altruistic) kidney donation from both professional’s and patient’s perspectives: research protocol for a national multicentre mixed-methods prospective cohort study

    Gare, Rebecca; Gogalniceanu, Petrut; Maple, Hannah et al.

    BMJ Open · 2017 · English · PubMed Central

    INTRODUCTION: Living donation accounts for over one-third of all kidney transplants taking place in the UK. (1) The concept of anonymously donating a kidney to a stranger (non-directed altruistic or unspecified kidney donation (UKD)) remains uncomfortable for some clinicians, principally due to…

  11. Journal Article Full text

    Inactivation of the CIC-DUX4 oncogene through P300/CBP inhibition, a therapeutic approach for CIC-DUX4 sarcoma

    Bosnakovski, Darko; Ener, Elizabeth T.; Cooper, Mark S. et al.

    Oncogenesis · 2021 · English · PubMed Central

    CIC-DUX4 sarcoma (CDS) is a highly aggressive and metastatic small round type of predominantly pediatric sarcoma driven by a fusion oncoprotein comprising the transcriptional repressor Capicua (CIC) fused to the C-terminal transcriptional activation domain of DUX4. CDS rapidly develops resistance…

  12. Journal Article Full text

    Discovery of a CNS active GSK3 degrader using orthogonally reactive linker screening

    Holmqvist, Andreas; Kocaturk, Nur Mehpare; Duncan, Christina et al.

    Nat Commun · 2025 · English · PubMed Central

    Bifunctional targeted protein degraders, also known as Proteolysis Targeting Chimeras (PROTACs), are an emerging drug modality that may offer a new approach for treating neurodegenerative diseases. Identifying chemical starting points for PROTACs remains a largely empirical process and the design…

  13. Journal Article Full text

    Chirality: a key parameter in chemical probes

    McGown, Andrew; Nafie, Jordan; Otayfah, Mohammed et al.

    RSC Chem Biol · 2023 · English · PubMed Central

    Many small molecule bioactive and marketed drugs are chiral. They are often synthesised from commercially available chiral building blocks. However, chirality is sometimes incorrectly assigned by manufacturers with consequences for the end user ranging from: experimental irreproducibility, wasted…

  14. Journal Article Full text

    Structure-Based Optimization of Pyridone α-Ketoamides as Inhibitors of the SARS-CoV-2 Main Protease

    Akula, Ravi Kumar; El Kilani, Haifa; Metzen, Alina et al.

    J Med Chem · 2025 · English · PubMed Central

    [Image: see text] The main protease M(pro) is a clinically validated target to treat infections by the coronavirus SARS-CoV-2. Among the first reported M(pro) inhibitors was the peptidomimetic α-ketoamide 13b, whose cocrystal structure with M(pro) paved the way for multiple lead-finding studies. We…

  15. Journal Article Full text

    Diastereomeric Resolution Yields Highly Potent Inhibitor of SARS-CoV-2 Main Protease

    Cooper, Mark S.; Zhang, Linlin; Ibrahim, Mohamed et al.

    J Med Chem · 2022 · English · PubMed Central

    [Image: see text] SARS-CoV-2 is the causative agent behind the COVID-19 pandemic. The main protease (M(pro), 3CL(pro)) of SARS-CoV-2 is a key enzyme that processes polyproteins translated from the viral RNA. M(pro) is therefore an attractive target for the design of inhibitors that block viral…

  16. Journal Article Full text

    Development of p300-targeting degraders with enhanced selectivity and onset of degradation

    Marsh, Graham P.; Cooper, Mark S.; Goggins, Sean et al.

    RSC Med Chem · 2025 · English · PubMed Central

    p300 and CBP are paralogous epigenetic regulators that are considered promising therapeutic targets for cancer treatment. Small molecule p300/CBP inhibitors have so far been unable to differentiate between these closely related proteins, yet selectivity is desirable in order to probe their distinct…

  17. Journal Article Full text

    Sharing regional capacity in deceased donor kidney transplantation: experience from a regional collaborative in a metropolitan area

    Wanigasekera, Tamara; Kim, Isaac; Maple, Hannah et al.

    Clin Kidney J · 2024 · English · PubMed Central

    BACKGROUND: Access to deceased donor kidney transplantation may be restricted in the event of resource limitation induced by extreme peaks in activity or local major incidents, which exceed centre capacity. An organ-sharing protocol was developed by the five London transplant units in 2019 to…

  18. Journal Article Full text

    Structure-Guided Design of ISOX-DUAL-Based Degraders Targeting BRD4 and CBP/EP300: A Case of Degrader Collapse

    Edmonds, Anthony K.; Balourdas, Dimitrios-Ilias; Marsh, Graham P. et al.

    J Med Chem · 2025 · English · PubMed Central

    [Image: see text] Degraders with dual activity against BRD4 and CBP/EP300 were designed. A structure-guided design approach was taken to assess and test potential exit vectors on the dual BRD4 and CBP/EP300 inhibitor, ISOX-DUAL. Candidate degrader panels revealed that VHL-recruiting moieties could…

  19. Journal Article Full text

    The Variation in Practice of the Living Donor Kidney Transplant Pathway in the UK: Results of a National Survey

    Nightingale, Katie; Stephenson, Josh; Sivaprakasam, Rajesh et al.

    Transpl Int · 2025 · English · PubMed Central

    Living donor kidney transplantation (LDKT) accounts for 35% of kidney transplants in the UK. The Organ Donation and Transplantation 2030 initiative underscores the necessity to enhance LDKT rates to meet growing demand. There is limited data on national variations in live donor workup pathways from…